New York, USA - 18 Nov `19Stress Response Pathways in Vitiligo

Official Title: Stress Response Pathways in Vitiligo: A Prospective, Investigator Initiated, Interventional Study With Two Arms

In brief: Current treatments vary in effectiveness and may not always be long lasting cases. The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Identifying a role for NF-κB signaling in vitiligo may improve or develop new therapies for vitiligo. Punch biopsy will be performed at the hospital.

Ages eligible: 18 Years to 50 Years

Start date: October 2015 (updated on November 18, 2019)

Completion date (estimated): December 2025

Location: New York University School of Medicine

Status: Active, recruiting

Contact: To learn more about this study, you or your doctor may contact Susan Cataldo by phone +1-212-263-5244 or by email: Please refer to this study by its identifier  NCT02797574. Principal Investigator Dr. Prashiela Manga, MD.

FAQOther Questions

  • How to get insurance coverage for vitiligo treatments?

    Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantial part of ...

  • Will it spread?

    Vitiligo activity may vary considerably from person to person. In a good number of patients the disease goes on for 3-4 years and then it settles down, with one or two stubborn...

  • What is vitiligo?

    Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...